Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells:: Up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein

被引:140
|
作者
Rölle, A
Mousavi-Jazi, M
Eriksson, M
Odeberg, J
Söderberg-Nauclér, C
Cosman, D
Kärre, K
Cerboni, C
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Stockholm, Sweden
[4] Amgen Inc, Dept Mol Biol, Seattle, WA 98101 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 02期
关键词
D O I
10.4049/jimmunol.171.2.902
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human CMV (HCMV) interferes with NK cell functions at various levels. The HCMV glycoprotein UL16 binds some of the ligands recognized by the NK-activating receptor NKG2D, namely UL16-binding proteins (ULBP) 1 and 2 and MHC class I-related chain B, possibly representing another mechanism of viral immune escape. This study addressed the expression and function of these proteins in infected cells. HCMV induced the expression of all three ULBPs, which were predominantly localized in the endoplasmic reticulum of infected fibroblasts together with UL16. However, while at a lower viral dose ULBP1 and 2 surface expression was completely inhibited compared to ULBP3, at a higher viral dose cell surface expression of ULBP1 and ULBP2 was delayed. The induction of ULBPs correlated with an increased dependency on NKG2D for recognition; however, the overall NK sensitivity did not change (suggesting that additional viral mechanisms interfere with NKG2D-independent pathways for recognition). Infection with a UL16 deletion mutant virus resulted in a different pattern compared to the wild type: all three ULBP molecules were induced with similar kinetics at the cell surface, accompanied by a pronounced, entirely NKG2D-dependent increase in NK sensitivity. Together our findings show that upon infection with HCMV, the host cell responds by expression of ULBPs and increased susceptibility to the NKG2D-mediated component of NK cell recognition, but UL16 limits these effects by interfering with the surface expression of ULBP1 and ULBP2.
引用
收藏
页码:902 / 908
页数:7
相关论文
共 39 条
  • [21] Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands
    Mueller, Steffen
    Zocher, Georg
    Steinle, Alexander
    Stehle, Thilo
    PLOS PATHOGENS, 2010, 6 (01)
  • [22] RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity
    Cao, Wei
    Xi, Xueyan
    Hao, Zhiyong
    Li, Wenjing
    Kong, Yan
    Cui, Lianxian
    Ma, Chi
    Ba, Denian
    He, Wei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (26) : 18922 - 18928
  • [23] UL16-Binding proteins, novel MHC class I-Related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells
    Sutherland, CL
    Chalupny, NJ
    Schooley, K
    VandenBos, T
    Cosman, D
    JOURNAL OF IMMUNOLOGY, 2002, 168 (02): : 671 - 679
  • [24] The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions
    Sutherland, CL
    Chalupny, NJ
    Cosman, D
    IMMUNOLOGICAL REVIEWS, 2001, 181 : 185 - 192
  • [25] Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for marine NKG2D
    Carayannopoulos, LN
    Naidenko, OV
    Fremont, DH
    Yokoyama, WM
    JOURNAL OF IMMUNOLOGY, 2002, 169 (08): : 4079 - 4083
  • [26] ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
    Cosman, D
    Müllberg, J
    Sutherland, CL
    Chin, W
    Armitage, R
    Fanslow, W
    Kubin, M
    Chalupny, NJ
    IMMUNITY, 2001, 14 (02) : 123 - 133
  • [27] Expression levels of UL16 binding protein 1 and natural killer group 2 member D in patients with gastric cancer
    Yoshimura, Kiyoshi
    Inoue, Moeko
    Asao, Tetsuhiko
    Fuse, Masanori
    Wada, Satoshi
    Kuramasu, Atsuo
    CANCER RESEARCH, 2017, 77
  • [28] Engaging the NKG2D receptor with a novel bispecific protein (ULBP2-antiCD138) activates NK cells and has potent antitumor activity against human multiple myeloma.
    von Strandmann, EP
    Hallek, M
    Engert, A
    BLOOD, 2005, 106 (11) : 372B - 372B
  • [29] Production of a novel bispecific protein ULBP1 x CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells
    Zhao, Qing
    Pang, Jie
    Yan, Fushan
    Jiang, Yi
    Cui, Dongxu
    Liu, Juanjuan
    Jing, Lei
    Li, Yuyin
    Liu, Zhenxing
    Tao, Li
    Zhao, Xiaocui
    Diao, Aipo
    PROTEIN EXPRESSION AND PURIFICATION, 2021, 178
  • [30] Knockdown of the UL-16 binding protein 1 promotes osteoblast differentiation of human mesenchymal stem cells by activating the SMAD2/3 pathway
    Zhen Lai
    Mingming Li
    Xiaodong Yang
    Zhenjie Xian
    BMC Musculoskeletal Disorders, 25